|
2025
|
Invention
|
Alkaline intraoral formulations.
There is provided an intraoral formulation comprising a solid, ... |
|
2023
|
Invention
|
Nicotine formulations.
There is provided a powder comprising a solid, porous chemically bonded c... |
|
|
Invention
|
Alkaline intraoral products.
There is provided an intraoral composition comprising an alkaline a... |
|
|
Invention
|
Alkaline intraoral products. There is provided an intraoral composition comprising an alkaline ac... |
|
|
Invention
|
Alkaline intraoral formulations. There is provided an intraoral formulation comprising a solid, p... |
|
|
Invention
|
Nicotine formulations. There is provided a powder comprising a solid, porous chemically bonded ce... |
|
2021
|
Invention
|
Devices for evaporation and inhalation of active agents.
There is provided an inhalation device ... |
|
2019
|
Invention
|
Transdermal drug administration device. A transdermal drug administration device comprising a dru... |
|
2018
|
Invention
|
Evaporation devices containing plant material.
There is provided an inhalation device for delive... |
|
|
Invention
|
Evaporation devices containing plant material. There is provided an inhalation device for deliver... |
|
2017
|
Invention
|
Abuse resistant formula. There is provided a sustained-release pharmaceutical composition compris... |
|
|
Invention
|
Devices for evaporation and inhalation of nicotine. There is provided an inhalation device for de... |
|
|
Invention
|
Devices for evaporation and inhalation of active agents. There is provided an inhalation device f... |
|
2016
|
Invention
|
Composition for sustained drug delivery comprising geopolymeric binder. The present invention rel... |
|
|
Invention
|
A transdermal drug administration device. A transdermal drug administration device comprising a d... |
|
2010
|
Invention
|
Composition for sustained drug delivery comprising geopolymeric binder.
The present in... |
|
|
Invention
|
Abuse resistant formulation. There is provided a sustained-release pharmaceutical compositi... |
